by PRI | Dec 4, 2023 | Microbiome Product Developer
Damien Rei CEO Startup developing gut microbiota derived treatment against neurodegenerative diseases...
by PRI | Sep 27, 2023 | News & Events
All PRI Members are invited to attend the annual Member Event – 7 November 2023. The Pharmabiotic Research Institute (PRI) is hosting its annual General Assembly & Member Event on 7 November 2023, in Ghent (Belgium). This Members-only meeting is our...
by PRI | Sep 27, 2023 | PRI Publications
Gabriel Vinderola, Céline Druart, Luis Gosálbez, Seppo Salminen, Nina Vinot and Sarah Lebeer (2023). Front. Pharmacol. 14:1239745. doi: 10.3389/fphar.2023.1239745 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515206 Diverse terms have been used in the literature to...
by PRI | Jul 7, 2023 | News & Events
Last week PRI Executive Director Magali Cordaillat-Simmons (PhD) was an invited expert at ISAPP’s annual meeting organized in Denver, Colorado. The International Scientific Association for Probiotics and Prebiotics (ISAPP) is “the international non-profit...
by PRI | Jul 3, 2023 | Microbiome Research & Technology (public)
Sarah Lebeer Research Professor Our ‘Laboratory of Applied Microbiology and Biotechnology’ is specialized in academic fundamental and applied research on the human microbiome (mainly vagina, upper respiratory tract & skin) and how microbiome-based...
